Key result
The Right to Try for Individualized Treatments Act presents significant regulatory and practical issues as an approach for accessing investigational individualized treatments.
This is the authors' abstract. We don't add key points for this paper.
This Viewpoint discusses investigational individualized treatments and outlines issues with the approach of the Right to Try for Individualized Treatments Act, or Right to Try 2.0.
Answers are grounded in this paper and cite their sources.
This viewpoint outlines regulatory and policy issues regarding the Right to Try for Individualized Treatments Act (Right to Try 2.0).
No takes yet. Share an insight, caveat, or question.
Lynch et al. (2026) studied this question. The Right to Try for Individualized Treatments Act presents significant regulatory and practical issues as an approach for accessing investigational individualized treatments.
Synapse has enriched 10 related papers. Consider them for comparative context: